SHL TeleMedicine Ltd. (SHLTN) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 35 PAGES: 37

SHL TeleMedicine Ltd. (SHL) is a medical technology company. It undertakes the development and marketing of personal telemedicine systems. The company provides comprehensive telemedicine solutions that include medical call center services to its end-users with a focus on cardiovascular and related diseases. Its major services include cardiac service, personal emergency response system, blood pressure monitoring system, pulmonary monitoring system, the CHF monitoring system and on-line medical services. It also offers products which transmit data to the operating medical call centers which include CardioSen’C, transmitter; TeleMarker, trans-telephonic cardiac blood testing device; Cardio'B, portable ECG device; Cardio Beeper, an ECG monitor-transmitter; TelePress, a remote blood pressure monitoring device; and TeleWeight, a trans-telephonic weight monitoring device. The company operates along with its subsidiaries in Israel, the US and Germany. SHL is headquartered in Tel Aviv, Israel.

More Info
									                   SHL TeleMedicine Ltd. (SHLTN) - Financial and Strategic SWOT
                                         Analysis Review
        Reference Code: GDME2618FSA                                                                                           Publication Date: AUG 2012

          Ashdar Building, 90 Yigal Alon St.                 Phone              +972 3 5612212                  Revenue           42.4 (million USD)
          Tel Aviv, Tel Aviv                                 Fax                +972 3 6242414                  Net Profit        4 (million USD)
                                                                                www.shl-
          67891                                              Website                                            Employees         367
                                                                                telemedicine.com
                                                                                SHLTN               [Swiss
          Israel                                             Exchange                                           Industry          Medical Equipment
                                                                                Exchange]

       Company Overview
       SHL TeleMedicine Ltd. (SHL) is an Israel based company. It operates in the development and marketing of personal telemedicine
       systems. It provides complete telemedicine solutions that include medical call center services to its end-users with a focus on
       cardiovascular and related diseases. The company, through its subsidiaries based in Israel, the US and Germany, operates in a
       single business segment named Personal Telemedicine. Personal Telemedicine is the procedure of transmitting medical data
       through communication networks, from a remote location to a medical call center for consulting and other purposes.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      SHL TeleMedicine Ltd., SWOT Analysis
         Yoram Alroy                         Director                                 Strengths                              Weaknesses
         Erez Alroy                          Director
                                                                                      Diversified Geographical               Declining Profitability
         Yariv Alroy                         Director                                 Presence
                                                                                                                             Information Overflow
         Ziv Carthy                          Director
                                                                                      CardioSen’C Technology
         Nehama Ronen                        Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     Rising Healthcare Expenditure Rapid Technological Change
         SHL TeleMedicine Ltd.
                                                                                      New Market Approvals and               Industry Consolidation
        Share Price (USD) as on 16-Aug-                                     7         Launches
        2012
        EPS (USD)                                                        0.38
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        Market Cap (million USD)                                           73        GlobalData

        Enterprise Value (million USD)                                     88
        Shares Outstanding (million)                                       10
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      May 30, 2012         SHL Telemedicine Reports Revenue Of $6.9m
                                                                                                           In Q1 2012
                                                                                      Mar 28, 2012         SHL Telemedicine          Reports    Revenue        Of
                                                                                                           $42.4m In 2011
                                                                                      Nov 29, 2011         SHL Telemedicine Reports Revenues Of
                                                                                                           $10.2m In Q3 2011
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData



       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




SHL TeleMedicine Ltd. (SHLTN) - Financial and Strategic SWOT                                                                     Reference Code: GDME2618FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                      Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       SHL TeleMedicine Ltd. - Key Facts .................................................................................................................................................... 5
       SHL TeleMedicine Ltd. - Key Employees ........................................................................................................................................... 6
       SHL TeleMedicine Ltd. - Key Employee Biographies ......................................................................................................................... 7
       SHL TeleMedicine Ltd. - Major Products and Services ...................................................................................................................... 8
       SHL TeleMedicine Ltd. - Medical Equipment Pipeline Products Data ................................................................................................ 9
          SHL TeleMedicine Ltd. Pipeline Products by Equipment Type ....................................................................................................... 9
          SHL TeleMedicine Ltd. Pipeline Products by Development Stage................................................................................................ 11
       SHL TeleMedicine Ltd. - History ....................................................................................................................................................... 13
       SHL TeleMedicine Ltd. - Company Statement ................................................................................................................................. 15
       SHL TeleMedicine Ltd. - Locations And Subsidiaries ....................................................................................................................... 16
          Head Office ................................................................................................................................................................................... 16
          Other Locations & Subsidiaries ..................................................................................................................................................... 16
       Section 2 – Company Analysis ......................................................................................................................................................... 17
       SHL TeleMedicine Ltd. - Business Description................................................................................................................................. 17
       SHL TeleMedicine Ltd. - SWOT Analysis ......................................................................................................................................... 18
          SWOT Analysis - Overview........................................................................................................................................................... 18
          SHL TeleMedicine Ltd. - Strengths ............................................................................................................................................... 18
             Strength - Diversified Geographical Presence .......................................................................................................................... 18
             Strength - CardioSen’C Technology .......................................................................................................................................... 18
             Strength - Improving Liquidity Reserves.................................................................................................................................... 18
          SHL TeleMedicine Ltd. - Weaknesses .......................................................................................................................................... 18
             Weakness - Declining Profitability ............................................................................................................................................. 18
             Weakness - Information Overflow ............................................................................................................................................. 19
             Weakness - Risk of Patient Data Breach .................................................................................................................................. 19
          SHL TeleMedicine Ltd. - Opportunities ......................................................................................................................................... 19
             Opportunity - Rising Healthcare Expenditure ............................................................................................................................ 19
             Opportunity - New Market Approvals and Launches ................................................................................................................. 19
             Opportunity - Growing Aged Population .................................................................................................................................... 20
             Opportunity - Growing Cardiovascular Diseases ....................................................................................................................... 20
          SHL TeleMedicine Ltd. - Threats .................................................................................................................................................. 20
             Threat - Rapid Technological Change ....................................................................................................................................... 20
             Threat - Industry Consolidation ................................................................................................................................................. 20
             Threat - Competitive Landscape ............................................................................................................................................... 20
       SHL TeleMedicine Ltd. - Key Competitors........................................................................................................................................ 21
       Section 3 – Company Financial Ratios ............................................................................................................................................. 22
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 22
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 22
       Performance Chart ........................................................................................................................................................................... 24
       Financial Performance...................................................................................................................................................................... 24
       Financial Ratios - Interim Ratios....................................................................................................................................................... 25
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 26


SHL TeleMedicine Ltd. (SHLTN) - Financial and Strategic SWOT                                                                                                    Reference Code: GDME2618FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                               
								
To top